Australia's most trusted source of pharma news
Monday, 19 August 2019
Lost Your Access?
Time to PBS starts to climb
Analysis shows higher average for 2018-19 financial year.
D-day for dodgy advertisers
Will there be another $10m TGA court case?
Govt backs antimicrobial centre
Awards $5m to fund local research and translation effort.
Sanofi deepens Smith Family role
Welcomes students under
Hunt announces opioid curbs
Regulatory changes aim to discourage misuse.
LEO buys skin drug rights
Will commercialise IL-17 inhibitor in Australia.
How fast is a fast-track?
Exclusive analysis of TGA pathways reveals all.
Gilead's CAR-T lands in MSAC
Seeking reimbursement in at least three lymphomas.
Monk retires from MA
Departs after 30 years, bringing back a familiar face.
Pharma bosses pitch their case
Lobbying for places on next MA Board already underway.
PBS 'best in world' says Hunt
Defends scheme from 'delayed access' attack in NPC address.
Global CBD leader explores Aust
Will it bring its dope blockbuster downunder?
Transfer pricing dos and don'ts
Glossy brochures, tall stories on ATO list of what not do to.
WA researchers hunt drug combo
Search for drug to combine with modified molecule to treat pancreatic cancer.
Oncologists' three PBAC wishes
Call for expanded access to IO class and adjuvant.
Medical Observer's 'abrupt' end
Long-standing GP publication shuttered, editor reveals.
Five new generics
Two for infections, one diabetes drug, plus more.
Imbruvica's double EU win
Janssen blockbuster combined with Roche drugs.
Top of the Hill
Time to elect industry prefects
There's nothing like a playground election to get kids buzzing.
Events & Conferences
© 2003 - 2019 Lush Media
Pharma in Focus
Jolly Good Design